Gene · 6278
Papers2,053
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,053
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Higher IL-9 Level is Associated with Psoriasis Vulgaris Complicated by Metabolic Syndrome. | Clin Cosmet Investig Dermatol | 2023 | 37641663 | PubTator, text mining | PubMed |
| The Post-Translational Modifications of Human Salivary Peptides and Proteins Evidenced by Top-Down Platforms. | Int J Mol Sci | 2023 | 37628956 | PubTator, text mining | PubMed |
| S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors. | Biomolecules | 2023 | 37627239 | PubTator, text mining | PubMed |
| Establishment of a prognostic model toward lung squamous cell carcinoma based on m7G-related genes in the cancer genome atlas. | Physiol Genomics | 2023 | 37575065 | PubTator, text mining | PubMed |
| Combined Salivary Proteome Profiling and Machine Learning Analysis Provides Insight into Molecular Signature for Autoimmune Liver Diseases Classification. | Int J Mol Sci | 2023 | 37569584 | PubTator, text mining | PubMed |
| Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models. | Int J Mol Sci | 2023 | 37569426 | PubTator, text mining | PubMed |
| Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer. | Nat Commun | 2023 | 37553345 | PubTator, text mining | PubMed |
| Clinical application of serum biomarkers for detecting and monitoring of chronic plaque psoriasis. | Front Mol Biosci | 2023 | 37546687 | PubTator, text mining | PubMed |
| MiR-125a-3p alleviates hyperproliferation of keratinocytes and psoriasis-like inflammation by targeting TLR4/NF-κB pathway. | Postepy Dermatol Alergol | 2023 | 37545827 | PubTator, text mining | PubMed |
| S100 proteins in head and neck squamous cell carcinoma (Review). | Oncol Lett | 2023 | 37545618 | PubTator, text mining | PubMed |
| A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer. | BMC Cancer | 2023 | 37543645 | PubTator, text mining | PubMed |
| The Latest Developments in Using Proteomic Biomarkers from Urine and Serum for Non-Invasive Disease Diagnosis and Prognosis. | Biomark Insights | 2023 | 37528936 | PubTator, text mining | PubMed |
| A Review of Existing and New Treatments for the Management of Hand Eczema. | J Cutan Med Surg | 2023 | 37496489 | PubTator, text mining | PubMed |
| N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model. | Sci Rep | 2023 | 37495686 | PubTator, text mining | PubMed |
| Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis. | Am J Rhinol Allergy | 2023 | 37491901 | PubTator, text mining | PubMed |
| A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans. | Front Immunol | 2023 | 37483588 | PubTator, text mining | PubMed |
| S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes. | Breast Cancer Res Treat | 2023 | 37450087 | PubTator, text mining | PubMed |
| Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis? | Int J Mol Sci | 2023 | 37445645 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles. | Healthcare (Basel) | 2023 | 37444683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6278/papers?page=9